NFE2L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.14193115968919E-14 |
Normal-vs-Stage2 |
1.04820000013106E-07 |
Normal-vs-Stage3 |
2.22044604925031E-16 |
Normal-vs-Stage4 |
1.65345515057425E-12 |
Stage1-vs-Stage2 |
6.675800E-01 |
Stage1-vs-Stage3 |
3.937700E-03 |
Stage1-vs-Stage4 |
1.107610E-02 |
Stage2-vs-Stage3 |
1.939370E-01 |
Stage2-vs-Stage4 |
2.088000E-01 |
Stage3-vs-Stage4 |
9.912000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
3.76169984050989E-10 |
Normal-vs-Asian |
3.561500E-03 |
Caucasian-vs-AfricanAmerican |
4.148800E-01 |
Caucasian-vs-Asian |
8.601800E-01 |
AfricanAmerican-vs-Asian |
8.877000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.686761841313E-12 |
Normal-vs-Female |
9.07662833782297E-12 |
Male-vs-Female |
2.750300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.79890546903039E-11 |
Normal-vs-Age(41-60Yrs) |
1.62747593179802E-12 |
Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
Normal-vs-Age(81-100Yrs) |
2.40309999999244E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.180500E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.661800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.855400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.725600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.503600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.735000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.993770E-02 |
Normal-vs-Grade 2 |
4.24660306919122E-13 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.70474745431193E-12 |
Grade 1-vs-Grade 2 |
3.530400E-01 |
Grade 1-vs-Grade 3 |
5.916000E-02 |
Grade 1-vs-Grade 4 |
2.912100E-02 |
Grade 2-vs-Grade 3 |
5.378600E-03 |
Grade 2-vs-Grade 4 |
2.817500E-03 |
Grade 3-vs-Grade 4 |
3.305400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.32670005484437E-09 |
Normal-vs-ccB subtype |
1.63113966777928E-12 |
ccA subtype-vs-ccB subtype |
2.25080000004763E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62536650805123E-12 |
Normal-vs-N1 |
2.26239999999711E-05 |
N0-vs-N1 |
5.044800E-01 |
|
|